Cheryl Leone

No ORCID on file · 3 papers in corpus · active 2019-2026

Study types

  • article 3

Condition tags

  • endometriosis 3
article 2026
Microvascular endothelial function is preserved during short-term estrogen suppression with Elagolix® in women with endometriosis
·doi:10.1152/physiol.2026.41.s1.2294842

Cardiovascular disease (CVD) risk is elevated in women with endometriosis (ENDO). Because estrogen is cardioprotective in some women, this CVD risk might be exacerbated by common ENDO treatments that suppress estrogen. The purpose of this s…

article 2024
The effect of acute estrogen suppression on cutaneous endothelium-dependent vasodilation in women with endometriosis
·doi:10.1152/physiol.2024.39.s1.421

Cardiovascular disease risk is elevated in women with endometriosis and may be exacerbated by treatments that suppress estrogen. The purpose of this study was to determine the effects of acute estrogen suppression on endothelial function in…

article 2019
Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2018.1559288

Bazedoxifene (BZA) paired with conjugated estrogens (CE) is the first tissue selective estrogen receptor complex (TSEC) approved by the United States Food and Drug Administration for the treatment of menopausal symptoms. Clinical trials in …